Roy D. Elterman

2.5k total citations
22 papers, 1.5k citations indexed

About

Roy D. Elterman is a scholar working on Genetics, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health. According to data from OpenAlex, Roy D. Elterman has authored 22 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 10 papers in Pediatrics, Perinatology and Child Health and 10 papers in Psychiatry and Mental health. Recurrent topics in Roy D. Elterman's work include Epilepsy research and treatment (10 papers), Glioma Diagnosis and Treatment (10 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Roy D. Elterman is often cited by papers focused on Epilepsy research and treatment (10 papers), Glioma Diagnosis and Treatment (10 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Roy D. Elterman collaborates with scholars based in United States, Canada and Germany. Roy D. Elterman's co-authors include Tracy A. Glauser, W. Donald Shields, Elaine Wyllie, Jo Anne Nakagawa, Ricardo Ayala, Wendy G. Mitchell, Zhihong Lu, Camille Orman, R. Reife and Gordon Pledger and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Cancer.

In The Last Decade

Roy D. Elterman

22 papers receiving 1.5k citations

Peers

Countries citing papers authored by Roy D. Elterman

Since Specialization

Citations

This map shows the geographic impact of Roy D. Elterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy D. Elterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy D. Elterman more than expected).

Fields of papers citing papers by Roy D. Elterman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy D. Elterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy D. Elterman. The network helps show where Roy D. Elterman may publish in the future.

Co-authorship network of co-authors of Roy D. Elterman

This figure shows the co-authorship network connecting the top 25 collaborators of Roy D. Elterman. A scholar is included among the top collaborators of Roy D. Elterman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy D. Elterman. Roy D. Elterman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In Memoriam: Steven LeRoy Linder, MD (1945–2015) 2016 ·Seminars in Pediatric Neurology ·Roy D. Elterman	1
2	Vigabatrin for the Treatment of Infantile Spasms: Final Report of a Randomized Trial 2010 ·Journal of Child Neurology ·Roy D. Elterman, W. Donald Shields, Richard M. Bittman, Sarah Torri, Stephen M. Sagar, Stephen D. Collins	72
3	Divalproex Sodium in Children with Partial Seizures: 12-Month Safety Study 2009 ·Pediatric Neurology ·Robert Lenz, Roy D. Elterman, Weining Robieson, (unknown), Mario Saltarelli	2
4	Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy 2008 ·Epilepsia ·James W. Wheless, Lionel Carmant, Martina Bebin, Joan A. Conry, Catherine Chiron, Roy D. Elterman, Michael Frost, Juliann Paolicchi, W. Donald Shields, Elizabeth A. Thiele, Mary L. Zupanc, Stephen D. Collins	85
5	Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma 2007 ·Journal of Neurosurgery Pediatrics ·Daniel C. Bowers, Lynn Gargan, Bradley E. Weprin, Arlynn F. Mulne, Roy D. Elterman, Louis Munoz, Cole A. Giller, Naomi Winick	31
6	Recurrent De Novo Mutations of SCN1A in Severe Myoclonic Epilepsy of Infancy 2006 ·Pediatric Neurology ·Jennifer A. Kearney, Anna Wiste, Ulrich Stephani, Michelle Trudeau, Anne Siegel, Rajesh RamachandranNair, Roy D. Elterman, Hiltrud Muhle, (unknown), W. Donald Shields, Miriam H. Meisler, Andrew Escayg	42
7	Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures 2006 ·Neurology ·Tracy A. Glauser, Ricardo Ayala, Roy D. Elterman, Wendy G. Mitchell, Camille Orman, (unknown), Zhihong Lu	221
8	Survival for children with medulloblastoma following tumor recurrence or progression 2005 ·Journal of Clinical Oncology ·Lynn Gargan, Arlynn F. Mulne, Roy D. Elterman, Bradley E. Weprin, Naomi Winick, Daniel C. Bowers	1
9	Study of the MIB-1 Labeling Index as a Predictor of Tumor Progression in Pilocytic Astrocytomas in Children and Adolescents 2003 ·Journal of Clinical Oncology ·Daniel C. Bowers, Lynn Gargan, Payal Kapur, Joan Reisch, Arlynn F. Mulne, Kenneth Shapiro, Roy D. Elterman, Naomi Winick, Linda R. Margraf	65
10	Nonperioperative strokes in children with central nervous system tumors 2002 ·Cancer ·Daniel C. Bowers, Arlynn F. Mulne, Joan Reisch, Roy D. Elterman, Louis Munoz, Timothy N. Booth, Kenneth Shapiro, (unknown)	2
11	Randomized trial of vigabatrin in patients with infantile spasms 2001 ·Neurology ·Roy D. Elterman, W. Donald Shields, (unknown), Jo Anne Nakagawa, (unknown)	176
12	Oral Methotrexate for Recurrent Brain Tumors in Children: A Pediatric Oncology Group Study 2000 ·The American journal of pediatric hematology/oncology ·Arlynn F. Mulne, Jonathan M. Ducore, Roy D. Elterman, Henry S. Friedman, Jeffrey P. Krischer, Larry E. Kun, Jonathan J. Shuster, Richard Kadota	16
13	Effectiveness, Tolerability, and Safety of Topiramate in Children with Partial‐Onset Seizures 2000 ·Epilepsia ·Frank J. Ritter, Tracy A. Glauser, Roy D. Elterman, Elaine Wyllie, (unknown)	72
14	A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children 1999 ·Neurology ·Roy D. Elterman, Tracy A. Glauser, Elaine Wyllie, R. Reife, Shu‐Chen Wu, Gordon Pledger, (unknown)	194
15	Surgical Treatment of Focal Epilepsy in Children; Results in 37 Patients 1997 ·Pediatric Neurosurgery ·(unknown), Derek A. Bruce, Richard B. North, Roy D. Elterman, Steven L. Linder, (unknown), (unknown)	19
16	Sudden Unexpected Death in Patients With Dandy-Walker Malformation 1995 ·Journal of Child Neurology ·Roy D. Elterman, John B. Bodensteiner, Jeffrey J. Barnard	2
17	Desmoplastic Infantile Gangliogliomas 1994 ·Neurosurgery ·Patricia K. Duffner, Peter C. Burger, Michael E. Cohen, Robert A. Sanford, Jeffrey P. Krischer, Roy D. Elterman, Patricia A. Aronin, Jeanette Pullen, Marc E. Horowitz, Andrew D. Parent, Paul Martin, Larry E. Kun	56
18	Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy 1994 ·Journal of neurosurgery ·Roger J. Packer, Leslie N. Sutton, Roy D. Elterman, Beverly Lange, Joel Goldwein, H. Stacy Nicholson, (unknown), James M. Boyett, Giulio J. D’Angio, (unknown), Gregory H. Reaman, Bruce H. Cohen, Derek A. Bruce, Lucy B. Rorke, Patricia Molloy, (unknown), Deborah A. Lafond, Audrey E. Evans, Luis Schut	369
19	Desmoplastic Infantile Gangliogliomas 1994 ·Neurosurgery ·Patricia K. Duffner, Peter C. Burger, Michael E. Cohen, Robert A. Sanford, Jeffrey P. Krischer, Roy D. Elterman, Patricia A. Aronin, Jeanette Pullen, Marc E. Horowitz, Andrew D. Parent, Paul Martin, Larry E. Kun	2
20	Partial trisomy 18 with minimal anomalies: Lack of correspondence between phenotypic manifestations and triplicated loci along chromosome 18 1990 ·American Journal of Medical Genetics ·Golder N. Wilson, (unknown), Roy D. Elterman, Nancy R. Schneider	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact